Shopping Cart 0
Cart Subtotal
USD 0

In-Vitro Diagnostics (IVD) Market Research Report, By Product & Services (Reagents & Kits, Instruments, Data management software), By Applications (Infectious Diseases,Non-infectious diseases), By End User- Global Forecast Till 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4450

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Introduction

In-vitro diagnostics (IVD) are medical devices, reagents, and accessories used to perform tests on samples, (e.g., blood, urine, and tissue) taken from the human body to help detect infection, diagnose a medical condition, and prevent disease. The aging population and the increasing prevalence of cancer and infectious diseases in developing countries, rising acceptance of molecular diagnostics in personalized medicines, change in lifestyle, increasing prevalence of chronic diseases, and an increasing number of private diagnostic centers drive the growth of the global in-vitro diagnostics market. Cardiovascular diseases (CVD) are considered as the biggest cause of death globally with an estimated 17.7 million deaths by CVD in 2015, representing 31% of all the global deaths as per the World Health Organization (WHO) statistics.

The global in-vitro diagnostics market is expected to reach a market value of USD 1,02,555 million by 2023 from USD 64,390 million in 2017 and is expected to register a CAGR of 8.16% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 39.4% share, followed by Europe with a share of 31.32%. The market growth in the Americas is attributed to the increase in the population suffering from chronic diseases.

The global in-vitro diagnostics market has been segmented based on products and services, technology, application, end user, and region.

The global in-vitro diagnostics market, by products and services, has been segmented into reagents and kits, instruments, and data management software and services.

The global in-vitro diagnostics market, by technology, has been segmented into clinical chemistry, immunoassay/immunochemistry, molecular diagnostics, microbiology, hematology, and others.

The global in-vitro diagnostics market, by application, has been segmented into infectious diseases and non-infectious diseases.

By end user, the global in-vitro diagnostics market has been segmented into hospitals, laboratories, academic institutes, and others.

Key Players

F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Siemens, and Thermo Fisher Scientific.

Study Objectives

To provide a comprehensive analysis of the in-vitro diagnostics industry and its sub-segments in the global market, thereby providing a detailed structure of the industry

To provide detailed insights into factors driving and restraining the growth of the global in-vitro diagnostics market

To estimate the market size of in-vitro diagnostics from 2015 to 2023 for different regions. Wherein, 2015 to 2016 would be the historic period, 2017 shall be the base year, and 2018 to 2023 will be the forecast period for the study

To analyze the global in-vitro diagnostics market, on the basis of four main geographies, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa

To compare products with respect to various players in the market

To provide country-wise market value analysis for various segments of the in-vitro diagnostics market

To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market

To provide distribution chain analysis/value chain for the in-vitro diagnostics market

Target Audience

Pharmaceutical Companies

Biotechnology Companies

Government Research Institutes

Academic Institutes and Universities

Key Findings

The global in-vitro diagnostics market is expected to reach USD 102,555 million by 2023 from USD 55,771 million in 2017 and is expected to register a CAGR of 8.16% during the forecast period from 2018 to 2023

On the basis of products and services, the reagents and kits segment accounted for the largest market share and is projected to register a CAGR of 8.02% from 2018 to 2023

Based on technology, the clinical chemistry segment accounted for the largest market share and is anticipated to register a CAGR of 8.59% from 2018 to 2023.

Based on application, the infectious disease segment accounted for the largest market share and is anticipated to register a CAGR of 8.01% from 2018 to 2023.

Based on end user, the hospitals segment held the largest market share of 46.4% in 2017 and is projected to register a CAGR of 7.69% during the forecast period

The Americas is expected to hold the largest share of the global in-vitro diagnostics market at a CAGR of 7.61% from 2018 to 2023.

Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 8.72% from 2018 to 2023.

Regional Analysis

Americas

o North America

US

Canada

o South America

Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o Australia

o Rest of Asia-Pacific

Middle East & Africa

o Middle East

o Africa

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Scope of Study

2.2 Research Objective

2.3 List of Assumptions

2.4 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Rising prevalence of chronic and infectious diseases

4.2.2 Growing awareness of personalized medicine

4.2.3 Increasing adoption of point-of-care testing

4.2.4 Rising investments in research and development and collaborations between companies and public organizations

4.3 Restraints

4.3.1 Unfavorable reimbursement scenario

4.3.2 Lack of standardization and transparency

4.3.3 Information and interest gap between investors and developers

4.4 Opportunities

4.4.1 Recent technological advancements have increased the appeal of in-vitro diagnostics

4.4.2 Developing economies provide an unserved market for in-vitro diagnostics

4.4.3 Growing significance of companion diagnostics

5 Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 Primary activities

5.2.2 Secondary Activities

6 Global In-Vitro Diagnostics Market, By Product & Services

6.1 Introduction

6.1.1 Reagents & Kits

6.1.2 Instruments

6.1.3 Data Management Software

7 Global In-Vitro Diagnostics Market, By Technology

7.1 Introduction

7.1.1 Immunoassay/Immunochemistry

7.1.2 Clinical Chemistry

7.1.3 Molecular Diagnostics

7.1.4 Microbiology

7.1.5 Hematology

8 Global In-Vitro Diagnostics Market, By Application

8.1 Introduction

8.1.1 Infectious Diseases

8.1.2 Non-Infectious Diseases

9 Global In-Vitro Diagnostics Market, By End User

9.1 Introduction

9.1.1 Hospitals

9.1.2 Laboratories

9.1.3 Academic Institutes

10 Global In-Vitro Diagnostics Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.4 Western Europe

10.4.1 Germany

10.4.2 UK

10.4.3 France

10.4.4 Spain

10.4.5 Italy

10.4.6 Rest of Western Europe

10.4.7 Eastern Europe

10.5 Asia-Pacific

10.5.1 China

10.5.2 Japan

10.5.3 India

10.5.4 Australia

10.5.5 Rest of Asia-Pacific

10.6 Middle East & Africa

10.6.1 Middle East

10.6.2 Africa

11 Competitive Landscape

11.1 Competitive Scenario

11.1.1 Introduction

11.2 Company Market Share Analysis

11.2.1 Introduction

11.3 Key Developments

12 Company Profile

12.1 F. Hoffmann-La Roche AG

12.1.1 Company Overview

12.1.2 Financial Overview

12.1.3 Products & Services Offered

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategy

12.2 Abbott Laboratories

12.2.1 Company Overview

12.2.2 Financial Overview

12.2.3 Products & Services Offered

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.2.6 Key Strategy

12.3 Siemens AG

12.3.1 Company Overview

12.3.2 Financial Overview

12.3.3 Products & Services Offered

12.3.4 Key Developments

12.3.5 SWOT Analysis

12.3.6 Key Strategy

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Company Overview

12.4.2 Financial Overview

12.4.3 Products & Services Offered

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.4.6 Key Strategy

12.5 Qiagen N.V.

12.5.1 Company Overview

12.5.2 Financial Overview

12.5.3 Products & Services Offered

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.5.6 Key strategy

12.6 BioMerieux S.A.

12.6.1 Company Overview

12.6.2 Financial Overview

12.6.3 Products & Services Offered

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.6.6 Key Strategy

12.7 Becton, Dickinson and Company

12.7.1 Company Overview

12.7.2 Financial Overview

12.7.3 Products & Services Offered

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.7.6 Key Strategy

12.8 DiaSorin S.p.A

12.8.1 Company Overview

12.8.2 Financial Overview

12.8.3 Products & Services Offered

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.8.6 Key Strategy

12.9 Ortho Clinical Diagnostics (Part of Johnson & Johnson Services Inc.)

12.9.1 Company Overview

12.9.2 Financial Overview

12.9.3 Products & Services Offered

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.9.6 Key Strategy

12.1 Grifols S.A.

12.10.1 Company Overview

12.10.2 Financial Overview

12.10.3 Products & Services Offered

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.10.6 Key Strategy

12.11 Danaher Corporation

12.11.1 Company Overview

12.11.2 Financial Overview

12.11.3 Products & Services Offered

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.11.6 Key Strategy

12.12 Sysmex Corporation

12.12.1 Company Overview

12.12.2 Financial Overview

12.12.3 Products & Services Offered

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.12.6 Key Strategy

12.13 Thermo Fisher Scientific

12.13.1 Company Overview

12.13.2 Financial Overview

12.13.3 Products & Services Offered

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.13.6 Key Strategy

13 Appendix

13.1 Discussion Blue Print


List Of Figure

List of Figures:

FIGURE 1 GLOBAL IN-VITRO DIAGNOSTICS MARKET: MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS OF MRFR

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 4 VALUE CHAIN

FIGURE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2017 & 2023 (USD MILLION)

FIGURE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2017 & 2023 (USD MILLION)

FIGURE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)

FIGURE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2017 & 2023 (USD MILLION)

FIGURE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2017 & 2023 (USD MILLION)

FIGURE 10 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION COUNTRY 2017 (%)

FIGURE 11 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 12 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2017 (%)

FIGURE 13 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 14 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)

FIGURE 15 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2017 (%)

FIGURE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (%)

FIGURE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET, MARKET SHARE ANALYSIS 2017 (%)


List Of Table

List of Tables:

TABLE 1 MARKET SYNOPSIS

TABLE 2 LIST OF ASSUMPTIONS

TABLE 3 PERSONALIZED THERAPY AUTHORIZED IN GERMANY

TABLE 4 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS & KITS, BY REGION 2015-2023 (USD MILLION)

TABLE 6 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2015-2023 (USD MILLION)

TABLE 7 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR DATA MANAGEMENT SOFTWARE, BY REGION 2015-2023 (USD MILLION)

TABLE 8 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR SERVICES, BY REGION 2015-2023 (USD MILLION)

TABLE 9 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 10 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 11 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 12 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY REGION 2015-2023 (USD MILLION)

TABLE 13 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 14 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION 2015-2023 (USD MILLION)

TABLE 15 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 16 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION 2015-2023 (USD MILLION)

TABLE 17 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR MICROBIOLOGY, BY REGION 2015-2023 (USD MILLION)

TABLE 18 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION 2015-2023 (USD MILLION)

TABLE 19 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 20 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION 2015-2023 (USD MILLION)

TABLE 21 GLOBAL IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 22 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR NON-INFECTIOUS DISEASES, BY REGION 2015-2023 (USD MILLION)

TABLE 23 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 24 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION 2015-2023 (USD MILLION)

TABLE 25 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY REGION 2015-2023 (USD MILLION)

TABLE 26 GLOBAL IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC INSTITUTES, BY REGION 2015-2023 (USD MILLION)

TABLE 27 GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 28 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 29 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 30 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 31 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 32 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 33 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 34 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 35 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 36 AMERICAS IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 37 AMERICAS IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 38 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 39 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 40 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 41 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 42 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 43 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 44 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 45 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 46 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 47 NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 48 US IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 49 US IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 50 US IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 51 US IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 52 US IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 53 US IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 54 US IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 55 US IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 56 US IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 57 CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 58 CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 59 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 60 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 61 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 62 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 63 CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 64 CANADA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 65 CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 66 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 67 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 68 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 69 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 70 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 71 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 72 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 73 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 74 SOUTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 75 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 76 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 77 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 78 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 79 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 80 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 81 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 82 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 83 EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 84 EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 85 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 86 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 87 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 88 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 89 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 90 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 91 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 92 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 93 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 94 WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 95 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 96 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 97 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 98 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 99 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 100 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 101 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 102 GERMANY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 103 GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 104 UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 105 UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 106 UK IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 107 UK IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 108 UK IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 109 UK IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 110 UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 111 UK IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 112 UK IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 113 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 114 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 115 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 116 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 117 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 118 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 119 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 120 FRANCE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 121 FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 122 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 123 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 124 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 125 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 126 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 127 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 128 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 129 SPAIN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 130 SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 131 ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 132 ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 133 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 134 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 135 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 136 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 137 ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 138 ITALY IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 139 ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 140 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 141 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 142 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 143 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 144 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 145 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE,

2015-2023 (USD MILLION)

TABLE 146 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 147 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE

2015-2023 (USD MILLION)

TABLE 148 REST OF WESTERN EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 149 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 150 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 151 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 152 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 153 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 154 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 155 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 156 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 157 EASTERN EUROPEIN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 158 ASIA PACFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY 2015-2023 (USD MILLION)

TABLE 159 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 160 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 161 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 162 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 163 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 164 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 165 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 166 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 167 ASIA-PACFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 168 CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 169 CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 170 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 171 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 172 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 173 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 174 CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 175 CHINA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 176 CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 177 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 178 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 179 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 180 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 181 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 182 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 183 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 184 JAPAN IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 185 JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 186 INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 187 INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 188 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 189 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 190 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 191 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 192 INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 193 INDIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 194 INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 195 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 196 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 197 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 198 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 199 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 200 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 201 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 202 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 203 AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 204 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 205 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 206 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 207 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 208 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 209 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 210 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 211 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 212 REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 213 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 214 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 215 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 216 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE,

2015-2023 (USD MILLION)

TABLE 217 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 218 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 219 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 220 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 221 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 222 MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 223 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 224 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 225 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 226 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE,

2015-2023 (USD MILLION)

TABLE 227 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 228 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 229 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 230 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 231 MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 232 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICES 2015-2023 (USD MILLION)

TABLE 233 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)

TABLE 234 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR IMMUNOASSAY/IMMUNOCHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 235 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR ENZYME-LINKED IMMUNOSORBENT ASSAY BY TYPE, 2015-2023 (USD MILLION)

TABLE 236 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR CLINICAL CHEMISTRY BY TYPE, 2015-2023 (USD MILLION)

TABLE 237 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR MOLECULAR DIAGNOSTICS BY TYPE, 2015-2023 (USD MILLION)

TABLE 238 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION 2015-2023 (USD MILLION)

TABLE 239 AFRICA IN-VITRO DIAGNOSTICS MARKET, FOR NON-INFECTIOUS DISEASES BY TYPE 2015-2023 (USD MILLION)

TABLE 240 AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 241 GLOBAL IN-VITRO DIAGNOSTICS MARKET: KEY DEVELOPMENT

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

F. Hoffmann-La Roche AG

Abbott Laboratories

Siemens AG

Bio-Rad Laboratories, Inc

Qiagen N.V.

BioMerieux S.A.

Becton, Dickinson and Company

DiaSorin S.p.A

Ortho Clinical Diagnostics (Part of Johnson & Johnson Services Inc.)

Grifols S.A.

Danaher Corporation

Sysmex Corporation

Thermo Fisher Scientific